908 Devices Inc.
Market Cap
$225.12M
P/E Ratio
-6.69
EPS
$-0.93
Dividend Yield
0.00%
52-Week Range
$3.55 — $9.34
Volume
229.84K
Avg Volume
375.49K
Beta
0.49
P/E (TTM)
-6.69
Forward P/E
—
PEG Ratio
0.02
P/S (TTM)
3.87
P/B (TTM)
1.51
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
0.13%
ROA (TTM)
0.10%
ROIC
—
Gross Margin
0.51%
Operating Margin
-0.70%
Net Margin
—
Debt/Equity
0.12
Current Ratio
4.24
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
-0.43%
EPS Growth (5Y)
-0.16%
Sales Growth (3Y)
+0.12%
Sales Growth (5Y)
+0.29%
EPS Est (This Year)
$-0.32
EPS Est (Next Year)
$-0.29
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$3.12
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
36.19M
Float
26.73M
Free Float %
73.86%
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
NASDAQ
IPO Date
2020-12-18
Employees
246
CEO
Kevin J. Knopp
Index Membership
—
Website
https://www.908devices.com
908 Devices Inc. (MASS) is a healthcare company in the medical - devices industry listed on the NASDAQ. With a market capitalization of $225.12M, a P/E ratio of -6.69, MASS is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare MASS against other stocks using dozens of fundamental and technical filters.
908 Devices Inc. (MASS) has a trailing twelve-month (TTM) P/E ratio of -6.69. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, 908 Devices Inc. (MASS) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
908 Devices Inc. (MASS) has a market capitalization of $225.12 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.